1 3 In the clinical trials stage of funding your company has a pre-money valuation of 4,721,185, and you are seeking an investment of 1,913,973 from a VC. You are in talks with a VC who expects 56% annual growth (IRR) and uses a multiplier of 5, and your company is aiming for an excitin 2 years from now What will be the post-money valuation of your company after the VC invests in this round of funding (You may round answer to whole number)